Mexican HIV-1 Protease Sequence Diversity

被引:0
作者
Hernandez-Sanchez, Pedro G. [1 ,2 ]
Guerra-Palomares, Sandra E. [1 ]
Arguello, J. Rafael [3 ]
Noyola, Daniel E. [2 ]
Garcia-Sepulveda, Christian A. [1 ]
机构
[1] Univ Autonoma San Luis Potosi, Fac Med, Lab Genom & Viral Humana, Ave Venustiano Carranza 2405, San Luis Potosi 78210, San Luis Potosi, Mexico
[2] Univ Autonoma San Luis Potosi, Fac Med, Dept Microbiol, San Luis Potosi, San Luis Potosi, Mexico
[3] Univ Autonoma Coahuila, Ctr Invest Biomed, Dept Inmunobiol Mol, Torreon, Coahuila, Mexico
关键词
protease; anti-retroviral mutations; molecular modelling; genetic diversity; Mexico; RESISTANCE MUTATIONS;
D O I
10.1089/aid.2019.0201
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Protease is one of three enzymes encoded within HIV's pol gene, responsible for the cleavage of viral Gag-Pol polypeptide into mature viral proteins and a target of current anti-retroviral therapy. Protease diversity analysis in Latin America has been lacking in spite of extensive studies of protease-inhibitor resistance mutations. We studied the diversity of 777 Mexican protease sequences and found that all were subtype B except one (CRF02_AG). Phylogenetic analysis suggested the existence of six different clades with geospecific contributions. Thirty-three percent of sites were conserved, 25% had conservative substitutions, and 41% exhibited physicochemical changes. The most conserved regions surrounded the active site, most of the flap domain, and a region between the 60's loop and C-terminal triad. A single sequence exhibited an active site mutation (T26S). Variable sites were mapped to a crystallographic structure, providing further insight into the distribution and functional relevance of variable sites among Mexican isolates.
引用
收藏
页码:161 / 166
页数:6
相关论文
共 16 条
  • [1] [Anonymous], 2016, Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, V2nd edn, P480
  • [2] HIV-1 protease: mechanism and drug discovery
    Brik, A
    Wong, CH
    [J]. ORGANIC & BIOMOLECULAR CHEMISTRY, 2003, 1 (01) : 5 - 14
  • [3] Hernandez-Sanchez PG, 2018, AIDS RES HUM RETROV, V34, P498, DOI [10.1089/AID.2017.0257, 10.1089/aid.2017.0257]
  • [4] ACTIVE HUMAN IMMUNODEFICIENCY VIRUS PROTEASE IS REQUIRED FOR VIRAL INFECTIVITY
    KOHL, NE
    EMINI, EA
    SCHLEIF, WA
    DAVIS, LJ
    HEIMBACH, JC
    DIXON, RAF
    SCOLNICK, EM
    SIGAL, IS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) : 4686 - 4690
  • [5] Los Alamos National Laboratory, ENTR SHANN ENTR 2
  • [6] Los Alamos National Laboratory, HIV SEQ AL
  • [7] Los Alamos National Laboratory, HIV SEQ DAT DISTR HI
  • [8] Louis JM, 2007, ADV PHARMACOL, V55, P261, DOI 10.1016/S1054-3589(07)55008-8
  • [9] Structural and Dynamical Aspects of HIV-1 Protease and Its Role in Drug Resistance
    Meher, Biswa Ranjan
    Patel, Seema
    [J]. DYNAMICS OF PROTEINS AND NUCLEIC ACIDS, 2013, 92 : 299 - 324
  • [10] On the relationship between docking scores and protein conformational changes in HIV-1 protease
    Mobaraki, Nabiollah
    Hemmateenejad, Bahram
    Weikl, Thomas R.
    Sakhteman, Amirhossein
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2019, 91 : 186 - 193